These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

743 related items for PubMed ID: 24923731

  • 1. All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause.
    Labrie F.
    J Steroid Biochem Mol Biol; 2015 Jan; 145():133-8. PubMed ID: 24923731
    [Abstract] [Full Text] [Related]

  • 2. DHEA, important source of sex steroids in men and even more in women.
    Labrie F.
    Prog Brain Res; 2010 Jan; 182():97-148. PubMed ID: 20541662
    [Abstract] [Full Text] [Related]

  • 3. DHEA and intracrinology at menopause, a positive choice for evolution of the human species.
    Labrie F, Labrie C.
    Climacteric; 2013 Apr; 16(2):205-13. PubMed ID: 23126249
    [Abstract] [Full Text] [Related]

  • 4. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology.
    Labrie F, Luu-The V, Labrie C, Simard J.
    Front Neuroendocrinol; 2001 Jul; 22(3):185-212. PubMed ID: 11456468
    [Abstract] [Full Text] [Related]

  • 5. Science of intracrinology in postmenopausal women.
    Labrie F, Bélanger A, Pelletier G, Martel C, Archer DF, Utian WH.
    Menopause; 2017 Jun; 24(6):702-712. PubMed ID: 28098598
    [Abstract] [Full Text] [Related]

  • 6. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone.
    Labrie F, Luu-The V, Labrie C, Bélanger A, Simard J, Lin SX, Pelletier G.
    Endocr Rev; 2003 Apr; 24(2):152-82. PubMed ID: 12700178
    [Abstract] [Full Text] [Related]

  • 7. Intracrinology and menopause: the science describing the cell-specific intracellular formation of estrogens and androgens from DHEA and their strictly local action and inactivation in peripheral tissues.
    Labrie F.
    Menopause; 2019 Feb; 26(2):220-224. PubMed ID: 30130283
    [Abstract] [Full Text] [Related]

  • 8. Extragonadal synthesis of sex steroids: intracrinology.
    Labrie F.
    Ann Endocrinol (Paris); 2003 Apr; 64(2):95-107. PubMed ID: 12773942
    [Abstract] [Full Text] [Related]

  • 9. Is dehydroepiandrosterone a hormone?
    Labrie F, Luu-The V, Bélanger A, Lin SX, Simard J, Pelletier G, Labrie C.
    J Endocrinol; 2005 Nov; 187(2):169-96. PubMed ID: 16293766
    [Abstract] [Full Text] [Related]

  • 10. Androgens in women are essentially made from DHEA in each peripheral tissue according to intracrinology.
    Labrie F, Martel C, Bélanger A, Pelletier G.
    J Steroid Biochem Mol Biol; 2017 Apr; 168():9-18. PubMed ID: 28153489
    [Abstract] [Full Text] [Related]

  • 11. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F, Bélanger A, Cusan L, Candas B.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [Abstract] [Full Text] [Related]

  • 12. The intracrinology of breast cancer.
    McNamara KM, Sasano H.
    J Steroid Biochem Mol Biol; 2015 Jan; 145():172-8. PubMed ID: 24751707
    [Abstract] [Full Text] [Related]

  • 13. Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks.
    Martel C, Labrie F, Archer DF, Ke Y, Gonthier R, Simard JN, Lavoie L, Vaillancourt M, Montesino M, Balser J, Moyneur É, other participating members of the Prasterone Clinical Research Group.
    J Steroid Biochem Mol Biol; 2016 May; 159():142-53. PubMed ID: 26972555
    [Abstract] [Full Text] [Related]

  • 14. Effect of exogenous estrogen on serum pregnenolone, cortisol, and androgens in postmenopausal women.
    Abraham GE, Maroulis GB.
    Obstet Gynecol; 1975 Mar; 45(3):271-4. PubMed ID: 163457
    [Abstract] [Full Text] [Related]

  • 15. Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women.
    Portman DJ, Labrie F, Archer DF, Bouchard C, Cusan L, Girard G, Ayotte N, Koltun W, Blouin F, Young D, Wade A, Martel C, Dubé R, other participating members of VVA Prasterone Group.
    Menopause; 2015 Dec; 22(12):1289-95. PubMed ID: 25968836
    [Abstract] [Full Text] [Related]

  • 16. A low dose (6.5 mg) of intravaginal DHEA permits a strictly local action while maintaining all serum estrogens or androgens as well as their metabolites within normal values.
    Labrie F, Martel C.
    Horm Mol Biol Clin Investig; 2017 Feb 01; 29(2):39-60. PubMed ID: 27997350
    [Abstract] [Full Text] [Related]

  • 17. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging.
    Labrie F, Bélanger A, Luu-The V, Labrie C, Simard J, Cusan L, Gomez JL, Candas B.
    Steroids; 1998 Feb 01; 63(5-6):322-8. PubMed ID: 9618795
    [Abstract] [Full Text] [Related]

  • 18. Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens.
    Labrie F, Martel C, Bérubé R, Côté I, Labrie C, Cusan L, Gomez JL.
    J Steroid Biochem Mol Biol; 2013 Nov 01; 138():359-67. PubMed ID: 23954500
    [Abstract] [Full Text] [Related]

  • 19. Adrenal androgens and intracrinology.
    Labrie F.
    Semin Reprod Med; 2004 Nov 01; 22(4):299-309. PubMed ID: 15635498
    [Abstract] [Full Text] [Related]

  • 20. Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA.
    Labrie F.
    Endocr Relat Cancer; 2006 Jun 01; 13(2):335-55. PubMed ID: 16728567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.